Connect with us

Health

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia – News-Medical.Net

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and…

Published

on

Article feature image

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Stretched Senegalese hospitals overwhelmed by third COVID wave – Reuters
Article feature image
An overview on fitness to drive for patients with cardiovascular diseases – News-Medical.Net